CUSIP No. 04522R101 | Page 9 of 9 Pages |
EXHIBIT A
JOINT FILING AGREEMENT
The undersigned hereby agree that the statement on Schedule 13G with respect to the Ordinary Shares of Aslan Pharmaceuticals Limited, dated as of March 20, 2023, is, and any amendments thereto (including amendments on Schedule 13D) signed by each of the undersigned shall be, filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended.
Dated: March 20, 2023 | ||
K2 HEALTHVENTURES EQUITY TRUST LLC | ||
By: | /s/ Anup Arora | |
Name: | Anup Arora | |
Title: | Managing Member | |
PARAG SHAH | ||
By: | /s/ Parag Shah | |
ANUP ARORA | ||
By: | /s/ Anup Arora |